European Region (EUR)

The curriculum aims to produce clinical oncologists who are flexible and adaptable with the ability to rapidly incoporate robust new evidence into clinical practice whilst ensuring the effective management of available resources, personnel and skill mix. 

 

The aim of this Curriculum and its certification process (e.g., the written theory exam and other Curriculum components) is to facilitate the graduation of a fellow to a specialist with a certain minimum standard of proficiency that can satisfy patients and regulators. This will form the initial step in the clinician's lifelong journey of learning.
 

"Background: Optimizing and ensuring the quality of surgical care is essential to improve the management and outcome of patients with cervical cancer.To develop a list of quality indicators for surgical treatment of cervical cancer that can be used to audit and improve clinical practice.

Methods: Quality indicators were developed using a four-step evaluation process that included a systematic literature search to identify potential quality indicators, in-person meetings of an ad hoc group of international experts, an internal validation process, and external review by a large panel of European clinicians and patient representatives.

Results: Fifteen structural, process, and outcome indicators were selected. Using a structured format, each quality indicator has a description specifying what the indicator is measuring. Measurability specifications are also detailed to define how the indicator will be measured in practice. Each indicator has a target which gives practitioners and health administrators a quantitative basis for improving care and organizational processes.

Discussion: Implementation of institutional quality assurance programs can improve quality of care, even in high-volume centers. This set of quality indicators from the European Society of Gynaecological Cancer may be a major instrument to improve the quality of surgical treatment of cervical cancer."






 

This document covers the diagnosis and treatment of cancer of the cervix. It also considers support of patients and consequences of cancer treatment. S


 

The present document ranges from screening and investigation through to management of early and advanced invasive cancer and on to metastatic disease. In addition, we have included survivorship and quality of life and we increasingly rely on nurse specialists to provide support to our patients throughout their cancer journey. The aspect of fertility preserving therapeutic approaches will also be addressed at the various aspects of management.


 

These updated guidelines are comprehensive and cover staging, management, follow-up, long-term survivorship, quality of life and palliative care.

 

This is a living guidelines for cancer screening, including cervical and breast cancer

 

This  guidelines for cervical screening is presented as a living document on a website, with different tabs for Cervical screening, screening flowchart, colposcopy and follow-up in special risk groups and after treatment. 
 

This guidance provides details of the cervical screening programme and direct the management and referral guidelines for colposcopy, treatment and follow up.